Please note: this site relies heavily on the use of javascript. Without a javascript-enabled browser, this site will not function correctly. Please enable javascript and reload the page, or switch to a different browser.
24  structures 161  species 2  interactions 1045  sequences 13  architectures

Family: P2X_receptor (PF00864)

Summary: ATP P2X receptor

Pfam includes annotations and additional family information from a range of different sources. These sources can be accessed via the tabs below.

This is the Wikipedia entry entitled "P2X purinoreceptor". More...

P2X purinoreceptor Edit Wikipedia article

ATP P2X receptor
Symbol P2X_receptor
Pfam PF00864
InterPro IPR001429
TCDB 1.A.7
OPM superfamily 202
OPM protein 3h9v

The ATP-gated P2X Receptor Cation Channel (P2X Receptor) Family (TC# 1.A.7) consists of cation-permeable ligand gated ion channels that open in response to the binding of extracellular adenosine 5'-triphosphate (ATP). They belong to a larger family of receptors known as the ENaC/P2X superfamily.[14] ENaC and P2X receptors have similar 3-D structures and are homologous.[15] P2X receptors are present in a diverse array of organisms including humans, mouse, rat, rabbit, chicken, zebrafish, bullfrog, fluke, and amoeba.[1]

Figure 1. Schematic representation showing the membrane topology of a typical P2X receptor subunit. First and second transmembrane domains are labeled TM1 and TM2.
Figure 2. Crystal structure of the zebrafish P2X4 receptor (deltaP2X4-B) channel as viewed from the side (left), extracellular (top right), and intracellular (bottom right) perspectives(PDB: 3I5D​)

Physiological roles

P2X receptors are involved in a variety of physiological processes,[1][2] including:

Tissue distribution

P2X receptors are expressed in cells from a wide variety of animal tissues. On presynaptic and postsynaptic nerve terminals and glial cells throughout the central, peripheral and autonomic nervous systems, P2X receptors have been shown to modulate synaptic transmission.[1][10] Furthermore, P2X receptors are able to initiate contraction in cells of the heart muscle, skeletal muscle, and various smooth muscle tissues, including that of the vasculature, vas deferens and urinary bladder. P2X receptors are also expressed on leukocytes, including lymphocytes and macrophages, and are present on blood platelets. There is some degree of subtype specificity as to which P2X receptor subtypes are expressed on specific cell types, with P2X1 receptors being particularly prominent in smooth muscle cells, and P2X2 being widespread throughout the autonomic nervous system. However, such trends are very general and there is considerable overlap in subunit distribution, with most cell types expressing more than one subunits. For example, P2X2 and P2X3 subunits are commonly found co-expressed in sensory neurons, where they often co-assemble into functional P2X2/3 receptors.

Basic structure and nomenclature

To date, seven separate genes coding for P2X subunits have been identified, and named to as P2X1 through P2X7, based on their pharmacological properties.[1][11]

receptor subtype HUGO gene name chromosomal location
P2X1 P2RX1 17p13.3
P2X2 P2RX2 12q24.33
P2X3 P2RX3 11q12
P2X4 P2RX4 12q24.32
P2X5 P2RX5 17p13.3
P2X6 P2RX6 22p11.21
P2X7 P2RX7 12q24

The proteins of the P2X receptors are quite similar in sequence (>35% identity), but they possess 380-1000 amino acyl residues per subunit with variability in length. The subunits all share a common topology, possessing two transmembrane domains (one about 30-50 residues from their N-termini, the other near residues 320-340), a large extracellular loop and intracellular carboxyl and amino termini (Figure 1)[1] The extracellular receptor domains between these two segments (of about 270 residues) are well conserved with several conserved glycyl residues and 10 conserved cysteyl residues. The amino termini contain a consensus site for protein kinase C phosphorylation, indicating that the phosphorylation state of P2X subunits may be involved in receptor functioning.[12] Additionally, there is a great deal of variability (25 to 240 residues) in the C termini, indicating that they might serve subunit specific properties.[13]

Generally speaking, most subunits can form functional homomeric or heteromeric receptors.[14] Receptor nomenclature dictates that naming is determined by the constituent subunits; e.g. a homomeric P2X receptor made up of only P2X1 subunits is called a P2X1 receptor, and a heteromeric receptor containing P2X2 and P2X3 subunits is called a P2X2/3 receptor. The general consensus is that P2X6 cannot form a functional homomeric receptor and that P2X7 cannot form a functional heteromeric receptor.[15][16]

Topologically, they resemble the epithelial Na+ channel proteins in possessing (a) N- and C-termini localized intracellularly, (b) two putative transmembrane segments, (c) a large extracellular loop domain, and (d) many conserved extracellular cysteyl residues. P2X receptor channels transport small monovalent cations, although some also transport Ca2+.[17]

Evidence from early molecular biological and functional studies has strongly indicated that the functional P2X receptor protein is a trimer, with the three peptide subunits arranged around an ion-permeable channel pore.[18] This view was recently confirmed by the use of X-ray crystallography to resolve the three-dimensional structure of the zebrafish P2X4 receptor[19](Figure 2). These findings indicate that the second transmembrane domain of each subunit lines the ion-conducting pore and is therefore responsible for channel gating.[20]

The relationship between the structure and function of P2X receptors has been the subject of considerable research using site-directed mutagenesis and chimeric channels, and key protein domains responsible for regulating ATP binding, ion permeation, pore dilation and desensitization have been identified.[21][22].

Activation and channel opening

Three ATP molecules are thought to be required to activate a P2X receptor, suggesting that ATP needs to bind to each of the three subunits in order to open the channel pore, though recent evidence suggests that ATP binds at the three subunit interfaces.[23][24] Once ATP binds to the extracellular loop of the P2X receptor, it evokes a conformational change in the structure of the ion channel that results in the opening of the ion-permeable pore. The most commonly accepted theory of channel opening involves the rotation and separation of the second transmembrane domain (TM) helices, allowing cations such as Na+ and Ca2+ to access the ion-conducting pore through three lateral fenestrations above the TM domains.[25][26] The entry of cations leads to the depolarization of the cell membrane and the activation of various Ca2+-sensitive intracellular processes.[27][28] The channel opening time is dependent upon the subunit makeup of the receptor. For example, P2X1 and P2X3 receptors desensitize rapidly (a few hundred milliseconds) in the continued presence of ATP, whereas the P2X2 receptor channel remains open for as long as ATP is bound to it.

Transport reaction

The generalized transport reaction is:

Monovalent cations or Ca2+ (out) ⇌ monovalent cations or Ca2+ (in)


The pharmacology of a given P2X receptor is largely determined by its subunit makeup.[11] Different subunits exhibit different sensitivities to purinergic agonists such as ATP, α,β-meATP and BzATP; and antagonists such as pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) and suramin.[1] Of continuing interest is the fact that some P2X receptors (P2X2, P2X4, human P2X5, and P2X7) exhibit multiple open states in response to ATP, characterized by a time-dependent increase in the permeabilities of large organic ions such as N-methyl-D-glucamine (NMDG+) and nucleotide binding dyes such as propidium iodide (YO-PRO-1). Whether this change in permeability is due to a widening of the P2X receptor channel pore itself or the opening of a separate ion-permeable pore is the subject of continued investigation.[1]

Synthesis and trafficking

P2X receptors are synthesized in the rough endoplasmic reticulum. After complex glycosylation in the Golgi apparatus, they are transported to the plasma membrane, whereby docking is achieved through specific members of the SNARE protein family.[14] A YXXXK motif in the C terminus is common to all P2X subunits and seems to be important for trafficking and stabilization of P2X receptors in the membrane.[29] Removal of P2X receptors occurs via clathrin-mediated endocytosis of receptors to endosomes where they are sorted into vesicles for degradation or recycling.[30]

Allosteric modulation

The sensitivity of P2X receptors to ATP is strongly modulated by changes in extracellular pH and by the presence of heavy metals (e.g. zinc and cadmium). For example, the ATP sensitivity of P2X1, P2X3 and P2X4 receptors is attenuated when the extracellular pH<7, whereas the ATP sensitivity of P2X2 is significantly increased. On the other hand, zinc potentiates ATP-gated currents through P2X2, P2X3 and P2X4, and inhibits currents through P2X1. The allosteric modulation of P2X receptors by pH and metals appears to be conferred by the presence of histidine side chains in the extracellular domain.[1] In contrast to the other members of the P2X receptor family, P2X4 receptors are also very sensitive to modulation by the macrocyclic lactone, ivermectin.[31] Ivermectin potentiates ATP-gated currents through P2X4 receptors by increasing the open probability of the channel in the presence of ATP, which it appears to do by interacting with the transmembrane domains from within the lipid bilayer.[32]


Human proteins containing this domain

P2RX1; P2RX2; P2RX3; P2RX4; P2RX5; P2RX7; P2RXL1; TAX1BP3

See also


  1. ^ a b c d e f g h i j North RA (2002). "Molecular physiology of P2X receptors". Physiological reviews. 82 (4): 1013–1067. PMID 12270951. doi:10.1152/physrev.00015.2002. 
  2. ^ Khakh BS, North RA (2006). "P2X receptors as cell-surface ATP sensors in health and disease". Nature. 442 (7102): 527–32. PMID 16885977. doi:10.1038/nature04886. 
  3. ^ Vassort G (2001). "Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium". Physiol. Rev. 81 (2): 767–806. PMID 11274344. 
  4. ^ Chizh BA, Illes P (2001). "P2X receptors and nociception". Pharmacol. Rev. 53 (4): 553–68. PMID 11734618. 
  5. ^ Fowler CJ, Griffiths D, de Groat WC (2008). "The neural control of micturition". Nat Rev Neurosci. 9 (6): 453–466. PMC 2897743Freely accessible. PMID 18490916. doi:10.1038/nrn2401. 
  6. ^ Gachet C (2006). "Regulation of Platelet Functions by P2 Receptors". Annual Review of Pharmacology and Toxicology. 46: 277–300. PMID 16402906. doi:10.1146/annurev.pharmtox.46.120604.141207. 
  7. ^ Wewers MD, Sarkar A (2009). "P2X7 receptor and macrophage function". Purinergic Signalling. 5 (2): 189–195. PMC 2686821Freely accessible. PMID 19214778. doi:10.1007/s11302-009-9131-9. 
  8. ^ Kawano A, Tsukimoto M, Noguchi T, Hotta N, Harada H, Takenouchi T, Kitani H, Kojima S (2012). "Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages". Biochemical and Biophysical Research Communications. 419 (2): 374–380. PMID 22349510. doi:10.1016/j.bbrc.2012.01.156. 
  9. ^ Burnstock G (2013). "Introduction to Purinergic Signalling in the Brain". Advances in Experimental Medicine and Biology. 986: 1–12. ISBN 978-94-007-4718-0. PMID 22879061. doi:10.1007/978-94-007-4719-7_1. 
  10. ^ Burnstock G (2000). "P2X receptors in sensory neurones". Br J Anaesth. 84 (4): 476–88. PMID 10823099. doi:10.1093/oxfordjournals.bja.a013473. 
  11. ^ a b Gever JR, Cockayne DA, Dillon MP, Burnstock G, Ford AP (2006). "Pharmacology of P2X channels". Pflugers Arch. 452 (5): 513–37. PMID 16649055. doi:10.1007/s00424-006-0070-9. 
  12. ^ Boué-Grabot E, Archambault V, Séguéla P (2000). "A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels". The Journal of Biological Chemistry. 275 (14): 10190–10195. PMID 10744703. doi:10.1074/jbc.275.14.10190. 
  13. ^ Surprenant A, North RA (2009). "Signaling at Purinergic P2X Receptors". Annual Review of Physiology. 71: 333–359. PMID 18851707. doi:10.1146/annurev.physiol.70.113006.100630. 
  14. ^ a b Kaczmarek-Hájek K, Lörinczi E, Hausmann R, Nicke A (2012). "Molecular and functional properties of P2X receptors—recent progress and persisting challenges". Purinergic Signalling. 8 (3): 375–417. PMC 3360091Freely accessible. PMID 22547202. doi:10.1007/s11302-012-9314-7. 
  15. ^ Barrera NP, Ormond SJ, Henderson RM, Murrell-Lagnado RD, Edwardson JM (2005). "Atomic Force Microscopy Imaging Demonstrates that P2X2 Receptors Are Trimers but That P2X6 Receptor Subunits Do Not Oligomerize". Journal of Biological Chemistry. 280 (11): 10759–10765. PMID 15657042. doi:10.1074/jbc.M412265200. 
  16. ^ Torres GE, Egan TM, Voigt MM (1999). "Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners". The Journal of Biological Chemistry. 274 (10): 6653–6659. PMID 10037762. doi:10.1074/jbc.274.10.6653. 
  17. ^ US Lapsed 6498022, Yale University School Of Medicine, "Isolated nucleic acid molecules encoding human carbonate transporter proteins, and uses thereof", assigned to Applera Corporation, Connecticut   This article incorporates text from this source, which is in the public domain.
  18. ^ Nicke A, Bäumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G (1998). "P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels". EMBO J. 17 (11): 3016–28. PMC 1170641Freely accessible. PMID 9606184. doi:10.1093/emboj/17.11.3016. 
  19. ^ Kawate T, Michel JC, Birdsong WT, Gouaux E (2009). "Crystal structure of the ATP-gated P2X4 ion channel in the closed state". Nature. 460 (7255): 592–598. PMC 2720809Freely accessible. PMID 19641588. doi:10.1038/nature08198. 
  20. ^ Migita K, Haines WR, Voigt MM, Egan TM (2001). "Polar Residues of the Second Transmembrane Domain Influence Cation Permeability of the ATP-gated P2X2 Receptor". Journal of Biological Chemistry. 276 (33): 30934–30941. PMID 11402044. doi:10.1074/jbc.M103366200. 
  21. ^ Egan TM, Samways DS, Li Z (2006). "Biophysics of P2X receptors". Pflugers Arch. 452 (5): 501–12. PMID 16708237. doi:10.1007/s00424-006-0078-1. 
  22. ^ Roberts JA, Vial C, Digby HR, Agboh KC, Wen H, Atterbury-Thomas A, Evans RJ (2006). "Molecular properties of P2X receptors". Pflugers Arch. 452 (5): 486–500. PMID 16607539. doi:10.1007/s00424-006-0073-6. 
  23. ^ Evans RJ (2008). "Orthosteric and allosteric binding sites of P2X receptors". Eur. Biophys. J. 38 (3): 319–27. PMID 18247022. doi:10.1007/s00249-008-0275-2. 
  24. ^ Ding S, Sachs F (1999). "Single channel properties of P2X2 purinoceptors". The Journal of General Physiology. 113 (5): 695–720. PMC 2222910Freely accessible. PMID 10228183. doi:10.1085/jgp.113.5.695. 
  25. ^ Cao L, Broomhead HE, Young MT, North RA (2009). "Polar Residues in the Second Transmembrane Domain of the Rat P2X2 Receptor That Affect Spontaneous Gating, Unitary Conductance, and Rectification". Journal of Neuroscience. 29 (45): 14257–14264. PMC 2804292Freely accessible. PMID 19906973. doi:10.1523/JNEUROSCI.4403-09.2009. 
  26. ^ Kawate T, Robertson JL, Li M, Silberberg SD, Swartz KJ (2011). "Ion access pathway to the transmembrane pore in P2X receptor channels". The Journal of General Physiology. 137 (6): 579–590. PMC 3105519Freely accessible. PMID 21624948. doi:10.1085/jgp.201010593. 
  27. ^ Shigetomi E, Kato F (2004). "Action Potential-Independent Release of Glutamate by Ca2+ Entry through Presynaptic P2X Receptors Elicits Postsynaptic Firing in the Brainstem Autonomic Network". Journal of Neuroscience. 24 (12): 3125–3135. PMID 15044552. doi:10.1523/JNEUROSCI.0090-04.2004. 
  28. ^ Koshimizu TA, Van Goor F, Tomić M, Wong AO, Tanoue A, Tsujimoto G, Stojilkovic SS (2000). "Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells". Molecular Pharmacology. 58 (5): 936–945. PMID 11040040. 
  29. ^ Chaumont S, Jiang LH, Penna A, North RA, Rassendren F (2004). "Identification of a Trafficking Motif Involved in the Stabilization and Polarization of P2X Receptors". Journal of Biological Chemistry. 279 (28): 29628–29638. PMID 15126501. doi:10.1074/jbc.M403940200. 
  30. ^ Royle SJ, Bobanović LK, Murrell-Lagnado RD (2002). "Identification of a Non-canonical Tyrosine-based Endocytic Motif in an Ionotropic Receptor". Journal of Biological Chemistry. 277 (38): 35378–35385. PMID 12105201. doi:10.1074/jbc.M204844200. 
  31. ^ Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA (1999). "Allosteric control of gating and kinetics at P2X(4) receptor channels". J. Neurosci. 19 (17): 7289–99. PMID 10460235. 
  32. ^ Priel A, Silberberg SD (2004). "Mechanism of ivermectin facilitation of human P2X4 receptor channels". J. Gen. Physiol. 123 (3): 281–93. PMC 2217454Freely accessible. PMID 14769846. doi:10.1085/jgp.200308986. 

External links

As of this edit, this article uses content from "1.A.7 ATP-gated P2X Receptor Cation Channel (P2X Receptor) Family", which is licensed in a way that permits reuse under the Creative Commons Attribution-ShareAlike 3.0 Unported License, but not under the GFDL. All relevant terms must be followed.

This page is based on a Wikipedia article. The text is available under the Creative Commons Attribution/Share-Alike License.

This tab holds the annotation information that is stored in the Pfam database. As we move to using Wikipedia as our main source of annotation, the contents of this tab will be gradually replaced by the Wikipedia tab.

ATP P2X receptor Provide feedback

No Pfam abstract.

External database links

This tab holds annotation information from the InterPro database.

InterPro entry IPR001429

P2X purinoceptors are cell membrane ion channels, gated by adenosine 5'-triphosphate (ATP) and other nucleotides; they have been found to be widely expressed on mammalian cells, and, by means of their functional properties, can be differentiated into three sub-groups. The first group is almost equally well activated by ATP and its analogue alpha,betamethylene-ATP, whereas, the second group is not activated by the latter compound. A third type of receptor (also called P2Z) is distinguished by the fact that repeated or prolonged agonist application leads to the opening of much larger pores, allowing large molecules to traverse the cell membrane. This increased permeability rapidly leads to cell death, and lysis.

Molecular cloning studies have identified seven P2X receptor subtypes, designated P2X1-P2X7. These receptors are proteins that share 35-48% amino acid identity, and possess two putative transmembrane (TM) domains, separated by a long (~270 residues) intervening sequence, which is thought to form an extracellular loop. Around 1/4 of the residues within the loop are invariant between the cloned subtypes, including 10 characteristic cysteines.

Studies of the functional properties of heterologously expressed P2X receptors, together with the examination of their distribution in native tissues, suggests they likely occur as both homo- and heteromultimers in vivo [PUBMED:10414359, PUBMED:12270951].

This entry represents all P2X purinoreceptor subtypes.

Gene Ontology

The mapping between Pfam and Gene Ontology is provided by InterPro. If you use this data please cite InterPro.

Domain organisation

Below is a listing of the unique domain organisations or architectures in which this domain is found. More...

Loading domain graphics...


We store a range of different sequence alignments for families. As well as the seed alignment from which the family is built, we provide the full alignment, generated by searching the sequence database (reference proteomes) using the family HMM. We also generate alignments using four representative proteomes (RP) sets, the UniProtKB sequence database, the NCBI sequence database, and our metagenomics sequence database. More...

View options

We make a range of alignments for each Pfam-A family. You can see a description of each above. You can view these alignments in various ways but please note that some types of alignment are never generated while others may not be available for all families, most commonly because the alignments are too large to handle.

Representative proteomes UniProt
Jalview View  View  View  View  View  View  View  View  View 
HTML View  View               
PP/heatmap 1 View               

1Cannot generate PP/Heatmap alignments for seeds; no PP data available

Key: ✓ available, x not generated, not available.

Format an alignment

Representative proteomes UniProt

Download options

We make all of our alignments available in Stockholm format. You can download them here as raw, plain text files or as gzip-compressed files.

Representative proteomes UniProt
Raw Stockholm Download   Download   Download   Download   Download   Download   Download   Download   Download  
Gzipped Download   Download   Download   Download   Download   Download   Download   Download   Download  

You can also download a FASTA format file containing the full-length sequences for all sequences in the full alignment.

HMM logo

HMM logos is one way of visualising profile HMMs. Logos provide a quick overview of the properties of an HMM in a graphical form. You can see a more detailed description of HMM logos and find out how you can interpret them here. More...


This page displays the phylogenetic tree for this family's seed alignment. We use FastTree to calculate neighbour join trees with a local bootstrap based on 100 resamples (shown next to the tree nodes). FastTree calculates approximately-maximum-likelihood phylogenetic trees from our seed alignment.

Note: You can also download the data file for the tree.

Curation and family details

This section shows the detailed information about the Pfam family. You can see the definitions of many of the terms in this section in the glossary and a fuller explanation of the scoring system that we use in the scores section of the help pages.

Curation View help on the curation process

Seed source: Pfam-B_1590 (release 2.1)
Previous IDs: none
Type: Family
Author: Bateman A
Number in seed: 72
Number in full: 1045
Average length of the domain: 268.40 aa
Average identity of full alignment: 34 %
Average coverage of the sequence by the domain: 81.89 %

HMM information View help on HMM parameters

HMM build commands:
build method: hmmbuild -o /dev/null HMM SEED
search method: hmmsearch -Z 26740544 -E 1000 --cpu 4 HMM pfamseq
Model details:
Parameter Sequence Domain
Gathering cut-off 20.0 20.0
Trusted cut-off 20.4 20.0
Noise cut-off 19.3 19.9
Model length: 368
Family (HMM) version: 18
Download: download the raw HMM for this family

Species distribution

Sunburst controls


Weight segments by...

Change the size of the sunburst


Colour assignments

Archea Archea Eukaryota Eukaryota
Bacteria Bacteria Other sequences Other sequences
Viruses Viruses Unclassified Unclassified
Viroids Viroids Unclassified sequence Unclassified sequence


Align selected sequences to HMM

Generate a FASTA-format file

Clear selection

This visualisation provides a simple graphical representation of the distribution of this family across species. You can find the original interactive tree in the adjacent tab. More...

Loading sunburst data...

Tree controls


The tree shows the occurrence of this domain across different species. More...


Please note: for large trees this can take some time. While the tree is loading, you can safely switch away from this tab but if you browse away from the family page entirely, the tree will not be loaded.


There are 2 interactions for this family. More...

P2X_receptor Adap_comp_sub


For those sequences which have a structure in the Protein DataBank, we use the mapping between UniProt, PDB and Pfam coordinate systems from the PDBe group, to allow us to map Pfam domains onto UniProt sequences and three-dimensional protein structures. The table below shows the structures on which the P2X_receptor domain has been found. There are 24 instances of this domain found in the PDB. Note that there may be multiple copies of the domain in a single PDB structure, since many structures contain multiple copies of the same protein seqence.

Loading structure mapping...